Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer

Anne Sofie Brems-Eskildsen*, Søren Linnet, Hella Danø, Adam Luczak, Peter Michael Vestlev, Erik Hugger Jakobsen, Jeppe Neimann, Charlotte Buch Jensen, Trine Dongsgaard, Sven Tyge Langkjer

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases